Cargando…
Impact of genetic variants on major bleeding after percutaneous coronary intervention based on a prospective multicenter registry
Although dual antiplatelet therapy is essential for patients who undergo percutaneous coronary interventions, the risk of bleeding remains an unsolved problem, and there is limited information on the potential relationship between genetic variants and major bleeding. We analyzed the correlations bet...
Autores principales: | Cha, Jung-Joon, Joo, Hyung Joon, Park, Jae Hyoung, Hong, Soon Jun, Ahn, Tae Hoon, Kim, Byeong-Keuk, Shin, WonYong, Ahn, Sung Gyun, Yoon, JungHan, Kim, Yong Hoon, Cho, Yun-Hyeong, Kang, Woong Chol, Kim, Weon, Lim, Young-Hyo, Gwon, HyeonCheol, Choi, WoongGil, Lim, Do-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815734/ https://www.ncbi.nlm.nih.gov/pubmed/33469058 http://dx.doi.org/10.1038/s41598-020-80319-9 |
Ejemplares similares
-
Impact of genetic variants on clinical outcome after percutaneous coronary intervention in elderly patients
por: Cha, Jung-Joon, et al.
Publicado: (2021) -
Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study
por: Joo, Hyung Joon, et al.
Publicado: (2018) -
Association between High Lipid Burden of Target Lesion and Slow TIMI Flow in Coronary Interventions
por: Lim, Subin, et al.
Publicado: (2022) -
Target Low-Density Lipoprotein-Cholesterol and Secondary Prevention for Patients with Acute Myocardial Infarction: A Korean Nationwide Cohort Study
por: Kim, Ju Hyeon, et al.
Publicado: (2022) -
Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trial
por: Lee, Seung-Jun, et al.
Publicado: (2023)